Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa

Movement Disorders

Volumn 22, Issue 3, 2007, Pages 420-424

  Pal, Pramod Kumar ^a   Sathyaprabha, Talakad N ^a   Tuhina, Prasad ^a   Thennarasu, Kandavel ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Parkinson's disease; Pulmonary function tests

Indexed keywords

LEVODOPA;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HUMAN; LUNG DISEASE; LUNG DYSPLASIA; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SPIROMETRY; SYMPTOMATOLOGY;

ADULT; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; LUNG DISEASES; MALE; MIDDLE AGED; PARKINSON DISEASE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 34147103892     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21330     Document Type: Article

References (15)

1. Sabate M, Rodriguez M, Mendez E, Enriquez E, Gonzalez I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. Arch Phys Med Rehabil 1996;77:29-34.
2. Obenour WH, Stevens PM, Cohen AA, McCutchen JJ. The causes of abnormal pulmonary function in Parkinson's disease. Am Rev Respir Dis 1972;105:382-387.
3. Neu HC, Connolly JJ, Jr, Schwertley FW, Ladwig HA, Brody AW. Obstructive respiratory dysfunction in parkinsonian patients. Am Rev Respir Dis 1967;95:33-47.
4. Weiner P, Inzelberg R, Davidovich A, et al. Respiratory muscle performance and the Perception of dyspnea in Parkinson's disease. Can J Neurol Sci 2002;29:68-72.
5. Paulson GD, Tafrate RH. Some "minor" aspects of parkinsonism, especially pulmonary function. Neurology 1970;20:14-17.
6. Vercueil L, Linard JP, Wuyam B, Pollak P, Benchetrit G. Breathing pattern in patients with Parkinson's disease. Respir Physiol 1999;118:163-172.
7. Tzelepis GE, McCool FD, Friedman JH, Hoppin FG, Jr. Respiratory muscle dysfunction in Parkinson's disease. Am Rev Respir Dis 1988;138:266-271.
8. Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci 1998;5:131-135.
9. Izquierdo-Alonso JL, Jimenez-Jimenez FJ, Cabrera-Valdivia F, Mansilla-Lesmes M. Airway dysfunction in patients with Parkinson's disease. Lung 1994;172:47-55.
10. De Pandis MF, Starace A, Stefanelli F, et al. Modification of respiratory function parameters in patients with severe Parkinson's disease. Neurol Sci 2002;23(Suppl. 2):S69-S70.
11. Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 1984;311:438-442.
12. Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meche FG, Stigt J. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:329-333.
13. Herer B, Arnulf I, Housset B. Effects of levodopa on pulmonary function in Parkinson's disease. Chest 2001;119:387-393.
14. Bogaard JM, Hovestadt A, Meerwaldt J, vd Meche FG, Stigt J. Maximal expiratory and inspiratory flow-volume curves in Parkinson's disease. Am Rev Respir Dis 1989;139:610-614.
15. Empey D. Mechanisms of bronchial hyperreactivity. Eur J Respir Dis Suppl 1982;117:33-40.